HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$23.88
Day range
$22.45 - $24.60
Year range
$5.35 - $24.60
Market cap
1.29B USD
Avg Volume
916.70K
P/E ratio
27.76
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 13.82M | 186.01% |
Operating expense | 41.12M | 20.32% |
Net income | -23.48M | 8.61% |
Net profit margin | -169.96 | 68.05% |
Earnings per share | -0.40 | 13.04% |
EBITDA | -26.85M | 6.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 247.71M | -12.15% |
Total assets | 384.51M | 24.94% |
Total liabilities | 49.56M | -23.80% |
Total equity | 334.94M | — |
Shares outstanding | 54.80M | — |
Price to book | 3.90 | — |
Return on assets | -17.25% | — |
Return on capital | -19.70% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -23.48M | 8.61% |
Cash from operations | -25.42M | -45.46% |
Cash from investing | -148.48M | -68.19% |
Cash from financing | 554.00K | -99.54% |
Net change in cash | -173.34M | -1,263.78% |
Free cash flow | -18.88M | -955.21% |
About
Founded
2014
Headquarters
Website
Employees
128
